Allopurinol Side Effects and Risk Management

Common Side Effects

• Acute gout attacks following initiation of allopurinol therapy now occur in less than 1% of patients when proper dosing protocols are followed. 1

Severe Hypersensitivity Reactions

• Allopurinol Hypersensitivity Syndrome (AHS) is a potentially life-threatening reaction with a 25% mortality rate. 2

Risk Factors for Hypersensitivity Reactions

• The HLA-B*58:01 genetic variant is particularly prevalent in Han-Chinese and Thai populations (regardless of kidney function), increasing the risk of severe hypersensitivity reactions to allopurinol. 2
• Korean patients with stage 3 or worse chronic kidney disease have a higher prevalence of the HLA-B*58:01 genetic variant, putting them at increased risk for allopurinol hypersensitivity reactions. 2

Drug Interactions

• Allopurinol requires 65-75% dose reduction of 6-mercaptopurine or azathioprine when used concomitantly due to significant drug interactions. 3
• Potential clinically significant interactions exist between allopurinol and cyclophosphamide and other cytotoxic agents. 3
• Allopurinol has documented interactions with multiple medications including dicumarol, thiazide diuretics, chlorpropamide, and cyclosporine. 4

Precautions to Minimize Side Effects

• Genetic testing for HLA-B*58:01 is recommended before initiating allopurinol therapy in high-risk ethnic groups to prevent severe hypersensitivity reactions. 2
• Dose reduction of at least 50% is recommended in patients with renal insufficiency to minimize the risk of adverse effects. 4
• Starting with low doses (100 mg daily) and titrating gradually is recommended to minimize the risk of acute gout attacks when initiating allopurinol therapy. 3